This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

ATANA BT Stock Overview

Provides biologically related information to customers in developing pharmaceutical drugs primarily in Europe and Asia. More details

ATANA BT fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	2/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Rewards

Revenue is forecast to grow 44.06% per year

Risk Analysis

Earnings are forecast to decline by an average of 25.7% per year for the next 3 years

Shares are highly illiquid

Has less than 1 year of cash runway

Does not have a meaningful market cap (SEK56M)

+ 3 more risks

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Attana AB Competitors

Price History & Performance

Summary of share price highs, lows and changes for Attana
Historical stock prices
Current Share Price	SEK 0.21
52 Week High	SEK 0
52 Week Low	SEK 0
Beta	0.75
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-10.42%

Recent updates

Shareholder Returns

	ATANA BT	SE Life Sciences	SE Market
7D	4.9%	-0.7%	0.4%
1Y	n/a	7.4%	-3.6%

Return vs Industry: Insufficient data to determine how ATANA BT performed against the Swedish Life Sciences industry.

Return vs Market: Insufficient data to determine how ATANA BT performed against the Swedish Market.

Price Volatility

Is ATANA BT's price volatile compared to industry and market?
ATANA BT volatility
ATANA BT Average Weekly Movement	n/a
Life Sciences Industry Average Movement	8.3%
Market Average Movement	6.8%
10% most volatile stocks in SE Market	13.6%
10% least volatile stocks in SE Market	4.1%

Stable Share Price: ATANA BT has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine ATANA BT's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2002	n/a	Teodor Aastrup	www.attana.com

Attana AB provides biologically related information to customers in developing pharmaceutical drugs primarily in Europe and Asia. The company offers analytical biosensor instruments for automated analysis of molecular interactions with cells and tissues; and contract research services. It serves academic institutions, biotech companies, and pharma companies.

Attana AB Fundamentals Summary

How do Attana's earnings and revenue compare to its market cap?
ATANA BT fundamental statistics
Market cap	SEK 56.17m
Earnings (TTM)	-SEK 14.66m
Revenue (TTM)	SEK 14.55m

3.9x

P/S Ratio

-3.8x

P/E Ratio

Is ATANA BT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ATANA BT income statement (TTM)
Revenue	SEK 14.55m
Cost of Revenue	SEK 4.99m
Gross Profit	SEK 9.56m
Other Expenses	SEK 24.23m
Earnings	-SEK 14.66m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	-0.054
Gross Margin	65.71%
Net Profit Margin	-100.76%
Debt/Equity Ratio	16.1%

How did ATANA BT perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/01/21 05:43
End of Day Share Price	2023/01/19 00:00
Earnings	2022/09/30
Annual Earnings	2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Attana AB is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Maria Karlsson Osipova	Penser Access

Attana NGM:ATANA BT Stock Report